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Abstract 
Background 
The relationship between infection with high-risk human papillomavirus (HPV) and cervical 
cancer is transforming cervical cancer prevention. HPV tests and vaccinations have recently 
become available. In Ireland, as elsewhere, primary care practitioners play a key role in 
prevention. ATHENS (A Trial of HPV Education and Support) aims to develop a theory-
based intervention to support primary care practitioners in their HPV-related practice. This 
study, the first step in the intervention development process, aimed to: identify HPV-related 
clinical behaviours that the intervention will target; clarify general practitioners’ (GPs’) and 
practice nurses’ roles and responsibilities; and determine factors that potentially influence 
clinical behaviour. A secondary objective was to informally assess the utility of the 
Theoretical Domains Framework (TDF) in understanding clinical behaviours in an area with 
an evolving evidence-base. 
Methods 
In-depth semi-structured telephone interviews were conducted with GPs and practice nurses. 
The topic guide, which contained open questions and HPV-related clinical scenarios, was 
developed through literature review and clinical experience. Interview transcripts were 
content-analysed using the TDF as the coding framework. 
Results 
19 GPs and 14 practice nurses were interviewed. The major HPV-related clinical behaviours 
were: initiating a discussion about HPV infection with female patients; 
offering/recommending HPV vaccination to appropriate patients; and answering patients’ 
questions about HPV testing. While the responsibility for taking smears was considered a 
female role, both male and female practitioners dealt with HPV-related issues. All 12 
theoretical domains arose in relation to HPV infection; the domains judged to be most 
important were: knowledge, emotion, social influences, beliefs about capabilities and beliefs 
about consequences. Eleven domains emerged in relation to HPV vaccination, with beliefs 
about consequences, social influences, knowledge and environmental context and resources 
judged to be the most important. Nine domains were relevant to HPV testing, with knowledge 
and beliefs about capabilities judged to be the most important. 
Conclusions 
The findings confirm the need for an intervention to support primary care practitioners 
around HPV and suggest it should target a range of theoretical domains. The TDF proved 
valuable in analysing qualitative data collected using a topic guide not specifically designed 
to capture TDF domains and understanding clinical behaviours in an area with an evolving 
evidence-base. 
Keywords 
Cervical screening, HPV, Clinical behaviours, GPs, Practice nurses, Primary care, TDF, 
Knowledge, Emotion, Social influences, Beliefs about capabilities, Beliefs about 
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Background 
More than 40 strains of human papillomavirus (HPV) are sexually transmitted and infect 
mucosal surfaces of the lower genital area [1]. Around 15 of these strains, including HPV16 
and HPV18, are known as ‘high-risk’ types because they are a necessary cause of cervical 
cancer [2]. These high-risk types are common [3], asymptomatic, and cleared by most women 
in a few months; in some women, however, persistent infection(s) can lead to cervical pre-
cancer and cancer [1]. 
It is generally accepted that, in the near future, cervical screening will be based on testing for 
infection with high-risk HPV types, rather than on conventional cytological smears [4-6]. 
Compared to smears, HPV testing (which can be conducted on residual smear samples) has 
higher negative predictive value and higher sensitivity for the detection of pre-cancer [7] 
making HPV-based screening likely to be effective [8,9] and cost-effective [10,11]. In 
addition, two prophylactic HPV vaccines have been developed [12]. For both vaccines, the 
vaccination schedule involves three doses at intervals within a six-month period and is most 
effective when administered before HPV exposure (i.e., among the sexually naive). 
Organised vaccination, together with screening, could prevent most cervical cancers [13]. 
Ireland, which has a mixed public-private healthcare system, is at the forefront of this 
transformation in cervical cancer prevention. A national screening programme, 
CervicalCheck, was rolled-out in autumn 2008. The programme invites women aged 25 to 64 
for a free smear in primary care every 3 to 5 years [14]. Prior to this, a woman could obtain a 
smear from her general practitioner (GP) or ‘Well Woman’ clinic for around €50. HPV 
testing is available through some practices and Well Woman clinics. CervicalCheck is 
currently introducing HPV testing in the follow-up of women treated for pre-cancer and is 
considering other uses, for example as a primary screening tool. HPV vaccination was 
licensed in males and females aged 9 to 26 in 2006, and can be purchased in primary care for 
around €600. In autumn 2010, a national schools-based vaccination programme started, 
providing free vaccination to girls aged around 12 [15]. These developments have been 
accompanied by changes in primary care, notably a move from single-doctor to multi-doctor 
practices supported by practice nurses. Traditionally, GPs were the primary smear takers, but 
practice nurses now play an important role in smear taking [16] and perform around one-half 
of the smears within CervicalCheck. 
In addition to providing smear tests, GPs and practice nurses are likely to be key sources of 
information and advice for patients on HPV infection, vaccination, and testing. For women, 
their GPs’ attitude influences their own prevention behaviours [17,18]. Moreover, healthcare 
professionals’ compliance with, and encouragement of, HPV vaccination is crucial in 
achieving high vaccination rates [19]. Therefore, GPs’ and practice nurses’ clinical practices 
in relation to HPV will impact on the success of cervical cancer prevention strategies. 
Little is known about what influences HPV-related clinical practice. Most research has 
focussed on practitioners’ knowledge, and while this is an important predictor of clinical 
behaviour, it is unlikely to be the sole influence [20,21]. A 2004 US family doctors’ survey 
found that substantial proportions were unaware of information on HPV infection relevant for 
patient counselling [22]. A 2007 survey of GPs in Ireland, using the same instrument (see 
Additional File 1), found lower knowledge levels than in the US survey [23], and important 
gaps in knowledge about HPV vaccination, consistent with findings from elsewhere [24-27]. 
More than 95 % of GPs desired national guidelines or policy on HPV vaccination and testing. 
HPV infection knowledge predicted HPV vaccination intentions: GPs with higher knowledge 
scores were significantly more likely to be willing to vaccinate sexually naive girls aged 
under 16 than those with lower knowledge scores. A 2007 study among US family doctors, 
found the Theory of Planned Behaviour [28] variables intentions, subjective norms 
(perceptions about whether others approve of vaccination), and perceived behavioural control 
(perceptions about whether the decision to vaccinate is within the control of the doctor) 
influenced HPV vaccination behaviour [29]. No studies have investigated determinants of 
practice nurses’ clinical behaviours in this field. 
ATHENS (A Trial of HPV Education and Support), which is being conducted under the 
umbrella of the CERVIVA research consortium (www.cerviva.ie) aims to develop a theory-
based intervention to support primary care practitioners in their practice in relation to HPV 
infection, vaccination, and testing. The current study is the first step in this intervention 
development process. The primary aims were to: identify HPV-related clinical behaviours 
that the intervention will target; clarify roles and responsibilities of GPs and practice nurses 
in these areas; and determine what influences these clinical behaviours. Because little is 
known about practice, or potentially relevant psychological theories, we used qualitative 
methods to generate data with richness and depth, and analysed this using the Theoretical 
Domains Framework (TDF) [30]. As the TDF was originally developed to aid understanding 
of clinical behaviours around evidence-based guidelines, a secondary objective was to reflect 
the utility of the TDF in a way that may inform other researchers who are considering using 
it. 
This article is one of a series documenting the development and use of the TDF to advance 
the science of implementation research. An overview of the articles contained in the series is 
provided in the introductory article [31]. 
Methods 
Participants and recruitment 
GPs and practice nurses working in Ireland were eligible to participate. GPs were recruited 
from a group of 145 participants in the 2007 survey [23], who were originally sampled from a 
national database and had indicated they were potentially willing to assist with further 
research. The group was diverse in terms of personal and practice characteristics and HPV 
infection knowledge and vaccination attitudes (in 2007). A purposive sample was recruited 
from this group, with strata defined in terms of variables that had been found in the 2007 
survey to be strongly associated with attitudes towards smear taking and HPV vaccination, 
namely: gender, years since graduation, area of practice location, and HPV infection 
knowledge score in 2007 (questions shown in Additional File 1). GPs were approached by 
post, in batches in a random order, and invited to take part in an interview about their views 
and experiences of cervical cancer prevention. Those interested returned a reply slip, and the 
study co-ordinator (LAMcS) contacted them to arrange an interview. Non-respondents 
received up to two reminder letters. As interviews progressed, particular attention was paid to 
recruiting GPs in unfilled strata. 
Since there is no national database of practice nurses, two approaches were used to identify 
potential participants. Firstly, all attendees at the annual national Irish Practice Nurses 
Association conference received a flyer and were invited to return this if they were interested 
in taking part. Secondly, invitation packs, compiled by the study team, were provided to 
professional development co-ordinators (PDCs) in six of the seven administrative areas 
across Ireland. The PDCs were each asked to select, at random, five nurses in their area to 
whom to send the packs. Nurses who returned the reply slip were contacted for interview. 
The only sampling stratum was area of practice and, as recruitment progressed, efforts were 
focussed on ensuring that nurses were recruited from urban and rural areas across the 
country. 
Ethical approval was obtained from the ethics committee of the Irish College of General 
Practitioners. Participants provided informed consent. 
Procedures 
Interviews were conducted by telephone by the study co-ordinator (LAMcS) and guided by a 
topic guide (Additional File 2). The topic guide was developed with input from a 
multidisciplinary team including investigators (LAMcS, LS, and SUD), the head of smear 
taker training at CervicalCheck, a practicing GP and practice nurse. It was informed by: 
literature review; a group discussion with the CervicalCheck smear taker training unit, who 
provide training sessions and a telephone helpline for GPs and practice nurses; discussions 
with the HPV vaccination team at the HSE National Immunisation Office and observation at 
one of their open meetings for GPs and practice nurses; and informal discussions with 
primary care practitioners. The guide included open questions and clinical scenarios designed 
to elicit information about HPV-related clinical behaviours, roles, and responsibilities in 
primary care, and drivers of clinical behaviours. It was organised in four clinical areas: 
cervical screening/smear taking, HPV infection, HPV vaccination, and HPV testing. The 
topic of cervical screening/smear taking was not the main focus of the study, but was 
included to set the context of the discussions about HPV. Participants were invited to discuss 
their experiences, views, barriers, and facilitators to practice, and support needs in each 
clinical area. The clinical scenarios covered HPV-related issues that could arise in practice 
and, potentially, present difficulties or challenges. Interviewees were asked to describe what 
they would do in each situation and how easy/difficult they would find it to handle. During 
the interview the interviewer chose which scenarios to present; these covered topics that had 
not already been raised by the interviewee, with the aim of eliciting as much information as 
possible. 
Recruitment continued until new issues ceased to emerge for GPs and practice nurses 
separately. Interviews lasted 16 to 50 minutes and were audio-recorded; three participants 
declined to be recorded, and so detailed notes were taken instead. Recordings were 
transcribed verbatim and anonymised. 
Analysis 
Content analysis was conducted following the framework analysis approach [32,33]. GP and 
practice nurse interviews were analysed together. The four clinical areas were considered 
separately. Two investigators (LAMcS, LS) read and re-read all transcripts, independently 
coded these, combined codes into subthemes and allocated these, and direct quotes from 
participants, to one of the 12 theoretical domains/themes of the TDF [30]. They held regular 
discussions to resolve disagreements and reach consensus and discussed uncertainties with a 
third investigator (JJF). To ensure analytical rigour, a second iteration of this process was 
performed, with re-review of transcripts to identify any important quotes or subthemes 
missed or misallocated. It was noted whether subthemes arose solely among GPs, practice 
nurses or both. The final synthesis and interpretation involved considering each 
theme/domain and subtheme in the context of the whole set of interviews. The 
strongest/dominant themes/domains were those: mentioned by most practitioners; where the 
most subthemes were identified; which were discussed at greatest length; and/or which were 
judged by the investigators to be invested with considerable intensity, passion, or sentiment 
by practitioners. 
Although interviews covered cervical screening, the results reported here concentrate 
primarily on HPV infection, vaccination, and testing. Illustrative quotes have been provided 
to supplement narrative descriptions. 
Results 
A total of 145 GP were contacted, and telephone interviews were conducted with 19. Of the 
30 practice nurses invited to take part through PDCs, ten were interviewed; a further four 
practice nurses, recruited at the annual conference, were also interviewed. Table 1 
summarises participants’ characteristics. 
Table 1 Characteristics of practitioners interviewed 
  GPs Practice nurses 
Gender Female 13 14 
Male 6 0 
Healthboard area HSE Mid-Eastern 4 3 
HSE North-Eastern 3 4 
HSE Southern 7 0 
HSE Western 5 7 
Location of practice City 6 6 
Other 13 8 
Solo GP practice Yes 6 7 
No 13 7 
Practice nurse Yes 16 - 
No 3 - 
Years since graduation * <10 years 2 n/a 
10-19 years 2 n/a 
20-39 years 14 n/a 
HPV information knowledge score * 
1
 High (11+) 5 n/a 
Medium (7-10) 10 n/a 
Low (<7) 3 n/a 
HPV vaccine attitude * Positive 10 n/a 
Negative / neutral 7 n/a 
* Data from 2007 GP survey (Murphy et al., 2008) [23] 
1
 Number of 13 factual questions about HPV infection that were answered correctly 
(Additional file 1) 
n/a = not available 
Clinical behaviours 
A limited number of HPV-related clinical behaviours were identified. As regards HPV 
infection, the key behaviour was initiating a discussion on this topic with female patients. 
This was more often done if the practitioner had a relevant ‘opening,’ such as a patient with 
HPV reported on her smear result, or a patient presenting with genital warts. A few 
participants, mainly practice nurses, reported routinely mentioning HPV infection to women 
attending for smears. For HPV vaccination, three behaviours were identified: 
offering/recommending vaccination to appropriate patients; discussing vaccination when 
raised by a patient; and administering the vaccine. The first of these was the most common 
behaviour. HPV testing was very rare among practitioners and answering patients’ questions 
was the most important behaviour in this regard. 
Roles and responsibilities 
Taking smears was considered a predominantly female role with responsibility falling on 
female GPs and practice nurses, who frequently stated that patients should always have the 
option of a female smear taker. Male GPs were less likely to perform smears and made 
comments like ‘I do an occasional one when a patient requests it.’ 
In contrast, HPV infection was discussed with patients by both male and female GPs and 
practice nurses. Similarly, responsibility for behaviours relating to HPV vaccination and HPV 
testing fell within the remit of both GPs and practice nurses. Sometimes, a GP described 
discussing HPV vaccination with patients and administering the first dose, then referring the 
patient to the practice nurse for the two subsequent doses. 
Factors that may influence clinical behaviours: HPV infection 
All 12 theoretical domains played a role in relation to discussing HPV infection with patients 
(Table 2). Memory attention and decision processes was least frequently raised, being 
mentioned by a single participant. The strongest domains were knowledge, emotion, social 
influences, beliefs about consequences and beliefs about capabilities. 
Table 2 Factors influencing behaviours related to HPV infection 
Theme / construct 
domain 
Subtheme / specific 
belief 
Practitioner 
* 
Sample quote 
GPs Practice 
Nurses 
1. Knowledge Don't know enough about 
it 
√ √ ‘Probably well the HPV now I have to say I’m not au fait as I say…’ 
- Practice nurse 5003 
 It’s an evolving area so 
it’s hard to keep up to 
speed 
√ √ 
 Not enough information 
available on it 
- √  
 Credibility of information 
sources 
√ √ 
2. Skill Difficulty initiating a 
discussion on HPV 
infection with a patient 
√ √ ‘We try and normalise the whole thing by saying, you know, if we took blood tests 
off everybody in the clinic you’d find something like 80 % of us had evidence of 
HPV infection at some point in the past’ 
- GP 0140  Ability to ‘normalise’ 
HPV infection when 
talking to patients 
√ √ 
 Difficulty explaining 
HPV infection in a way 
that patients can 
understand 
- √  
3. Social / 
professional role and 
identity 
Don’t want to pass 
judgement on patients’ 
sexual behaviours 
- √ ‘It’s a very mmm difficult situation and you don’t want to lay any blame 
- Practice nurse 5023 
4. Beliefs about 
capabilities 
Difficulty dealing with 
awkward or sensitive 
situations 
√ - ‘There is difficulty because it’s often mmm it very much depends on the context. 
You know, if mmm if the relationship has broken down or if they have suspicions, 
they can be a very distressing for women to mmm ask those questions’ 
 Easier to discuss with 
patients who are open or 
interested 
√ √ - GP 0058 
 More likely to discuss 
HPV infection with 
patients if: 
   
 Already doing a smear - √ 
 Patient asks for a 
prescription for ‘the pill’ 
√ - 
 Patient presents with 
genital warts 
√ - 
5. Beliefs about 
consequences 
When discussing HPV 
infection, patients might: 
  ‘You don’t know whether by highlighting it [HPV infection] that people might 
stop coming for smears in case it’s positive’ 
-Practice nurse 5002 Get embarrassed √ √ 
Be put off having smears - √  
Think they have a 
sexually transmitted 
disease 
- √ 
Think their partner is 
being unfaithful 
- √  
6. Motivation and 
goals 
Don’t think it’s necessary 
to discuss HPV infection 
with patients 
√ √ ‘I wouldn’t see any reason to [talk about HPV infection]’ 
-GP 0072 
Discussing HPV 
infection with patients is 
important 
√ -  
7. Memory, attention 
and decision 
processes 
Topic is not at the 
forefront of the 
practitioner’s mind 
√ - ‘It’s not sort of, of hopping on to the top of my mind....’ 
-GP 0090 
8. Environmental 
context and 
resources 
Don't have enough time 
for discussion 
√ √ ‘I suppose maybe to have more aids in very simple descriptions in different 
languages…it’s simple things that I draw out and explain to people. I don’t have 
that. I suppose it’s something we need to get together maybe and work on’ 
- Practice nurse 5001  Need aids for discussion - √ 
 Need leaflets about HPV 
to give to patients 
- √ 
9. Social influences Patients don't know 
anything about it 
√ √ ‘I would say that most people coming in for cervical screening do not understand 
or even know the association of HPV to it… They do not associate HPV and 
cervical cancer in any way whatsoever’ 
- Practice nurse 5043 
 Patients don't want to 
know about it 
√ √ 
 Need for more publicity √ - 
10. Emotion Sensitive topic because 
it's about patients' sexual 
behaviour 
√ √ ‘Well I mean the bottom line is that I think I’m em, along with most of my 
colleagues, are avoiding the subject. Because we know damn well that it’s about 
you know hhh you know behaviour you know sexual behaviour. And I mean it’s 
associated with sleeping with the wrong guy..... I think we’re avoiding. I think 
you’re right, we’re avoiding the topic cos we don’t want to go near it because it’s 
a can of worms’ 
- GP 0034 
 The practitioner might 
get embarrassed 
√ √  
11. Behavioural 
regulation 
Recognising 
opportunities to raise 
topic with patients 
√ √ ‘I try to work it [HPV infection] in sometimes when I’m talking to them initially 
about contraception and if they’re using the pill and stuff like that.’ 
- GP 0026 
 Having aids for the 
discussion available 
- √ 
 Having leaflets available 
to give to patients 
√ √ 
 Having a clear plan of 
what to say 
√ √  
12. Nature of the 
behaviour 
Don't routinely bring 
HPV infection up with 
patients 
√ √ ‘It’s not something that I on a regular basis discuss with people…’ 
- Practice nurse 5043 
* ✓ = Mentioned by at least one practitioner 
- = Not mentioned by any practitioners 
The knowledge domain had several layers. First, practitioners described a general lack of 
knowledge and need for more information. Second, the evidence-base was perceived as 
rapidly evolving, and practitioners reported difficulty keeping up-to-date. Third, practitioners 
questioned the credibility of some information sources. For example, they noted that much of 
the information on HPV came from pharmaceutical companies, and they considered it to be 
biased. In contrast, participants expressed confidence in CervicalCheck as an information 
source not just as regards smears, but also in relation to HPV. As regards emotion, there was 
a general belief that the whole area of HPV is ‘sensitive’ and ‘awkward’ as it relates to sexual 
behaviour. Practitioners were concerned about patient embarrassment and, for some, their 
own embarrassment. The strength of the emotions involved led practitioners to adopt coping 
strategies such as being ‘careful’ in what they said, ‘tiptoeing’ around the topic, or avoiding it 
altogether. Patient lack of interest or knowledge was given as another reason for not 
discussing HPV infection (social influences). In addition, some practitioners were reluctant to 
raise the topic because they felt it might discourage women from having smears (beliefs 
about consequences). In relation to beliefs about capabilities, both GPs and practice nurses 
indicated that they found it difficult to initiate a discussion on HPV infection without some 
kind of ‘opening,’ such as a direct question from the patient. 
As regards the skill domain, GPs observed that they found it difficult to explain HPV in a 
way that patients could understand. Practice nurses observed that discussing HPV infection 
could be seen as passing judgement on an individual’s sexual behaviour, which would be 
professionally inappropriate (social/professional role and identity). In terms of motivation 
and goals, some GPs questioned the need to discuss HPV infection with patients at all 
because the infection can resolve on its own and/or there is no treatment. A lack of time in 
consultations and lack of aids for discussion were noted in regard to environmental context 
and resources. Some practitioners recognised opportunities to raise the topic with patients 
(e.g., when a patient presented with genital warts or asked for a prescription for the 
contraceptive pill) (behavioural regulation). Overall, however HPV infection was not widely 
discussed with patients (nature of the behaviour). 
Factors that may influence clinical behaviours: HPV vaccination 
The only theoretical domain that did not emerge in relation to HPV vaccination was memory, 
attention and decision processes (Table 3). The dominant domains were beliefs about 
consequences, social influences, knowledge and environmental context and resources. 
Table 3 Factors influencing behaviours related to HPV vaccination 
Theme / construct 
domain 
Subtheme / specific belief Practitioner 
* 
Sample 
quote 
Theme / construct domain 
GPs Practice 
Nurse 
1. Knowledge Not enough information available 
about it 
- √ ‘I suppose the big difficulty with it rally is mmm what to 
do with girls who aare mmm maybe that little bit older..... 
You’re not quite sure if they have had sexual encounters 
or not and whether it’s still worthwhile giving it or not’ 
- GP 0058 
 Rapidly changing area - √ 
 Uncertainty over how long the 
protection afforded by vaccination will 
last 
√ √ 
 Uncertainty over whether to vaccinate 
older / sexually active girls or women 
√ - 
 Uncertainty over whether to vaccinate 
boys 
√ √ 
 Most of the information comes from 
pharmaceutical companies and is 
viewed as biased 
√ √  
2. Skill Difficulty of dealing with a 
consultation where both mother and 
daughter are present (and/or mother 
asking about vaccination for daughter) 
√ √ ‘It’s quite a tricky consultation [when mother and 
daughter are both present] and you’re very aware of 
everybody’s, the confidentiality issues for the girl, mmm 
for you know the mum who’s come with her, for all of the 
type of thing’ 
- Practice nurse 5001 
 Difficulty assessing whether a patient 
has been sexually active 
√ √ 
   √  
3. Social / 
professional role 
and identity 
Feel out of touch (because HPV 
vaccination programme is being 
delivered through schools) 
- √ ‘You see it’s very difficult and I find it’s quite difficult 
since most of my patients are GMS
§
 and in many of these 
houses there’ll be a few girls, and I know the people can’t 
afford the bloomin stuff ....’ 
- GP 0090 
4. Beliefs about 
capabilities 
Practitioners are not comfortable 
discussing HPV vaccination 
√ - ‘It’s a bit too new probably compared to some of the 
other, you know the baby vaccines that are out like they’re 
going donkeys years now and they seem fairly safe. I’m 
sure the other two [HPV vaccines] are as well, but I can’t 
guarantee it’ 
- Practice nurse 5020 
 The vaccine is too new to be 
considered in primary care 
- √ 
5. Beliefs about 
consequences 
HPV vaccination can cause serious side 
effects 
√ √ ‘Are you allowing them to be more sexually active by 
giving them the vaccine. .... I must admit personally 
speaking initially when I first saw I was oh my goodness 
you know girls will become more promiscuous’ 
 Vaccination might encourage 
promiscuity 
√ √ 
 Belief that vaccine is effective √ √ 
 Belief that vaccine is safe √ √ 
    - Practice nurse 5040 
6. Motivation and 
goals 
Don't think HPV vaccination is 
necessary 
√ - ‘I don’t know now......how much it’s [HPV vaccination] 
warranted’ 
- GP 0086 
7. Memory, 
attention and 
decision processes 
- - - - 
8. Environmental 
context and 
resources 
The cost is very high √ √ ‘I think the price is astronomical. And outrageous…’ 
- GP 0034 
 It would involve a lot of extra work for 
GPs to provide HPV vaccination 
√ - 
 HPV vaccine is not stocked in the 
surgery 
√ -  
9. Social influences If practitioner has a daughter they 
would vaccinate her 
√ √  
 Patients don't know anything about 
HPV vaccination 
√ √ ‘If it was daughter I’d do it [vaccinate her]’ 
- GP 0016 
 Parents don't want to know that their 
children are sexually active 
√ √  
 There has been a lot of negative 
publicity about HPV vaccination 
√ √ ‘That can be a little bit of a minefield there especially if 
you’ve got the mother and daughter in front of you’ 
- GP 0026 10. Emotion Nervousness about managing an HPV 
vaccination consultation when both 
mother and daughter are present 
√ √ 
11. Behavioural 
regulation 
Sourcing vaccine at a cheaper price √ √ ‘We got together as a group… and we sourced it as 
cheaply as we could because we bought it as a group so 
we got a group discount’ 
- Practice nurse 5001 
 Having written information available to 
provide to patients 
√ √ 
 Having posters advertising that the 
vaccine is available in the surgery / 
waiting rooms 
√ √ 
12. Nature of the 
behaviour 
Don't see patients in the relevant age 
group 
√ √ ‘I actually don’t see very many young you know, at the 
ages where I could see them around 12 or 13… I so rarely 
see children now’ 
- GP 0092 
* ✓ = Mentioned by at least one practitioner 
- = Not mentioned by any practitioners 
Some practitioners believed that HPV vaccination was effective and safe, but others had 
concerns about side effects (beliefs about consequences). For example, some raised the case 
of a schoolgirl in the UK who died shortly after receiving the vaccine in 2009. In general, 
practitioners who had daughters were more likely to have a positive attitude towards HPV 
vaccination (social influences). Others perceived that parents would think that HPV 
vaccination would encourage promiscuity in their children, and negative media publicity was 
cited by some as a reason for not discussing it with patients. The same knowledge issues 
arose for HPV vaccination as for HPV infection (i.e., lack of knowledge, need for more 
information, and credibility of information sources). The evolving evidence base emerged as 
especially challenging in relation to practice. For example, practitioners expressed 
considerable uncertainty over whether to vaccinate sexually active girls. Few were clear or 
certain of what to do when faced with this, and other related situations, in the clinic. Others 
were certain about what they would do and why, but their reported practice conflicted with 
current evidence. In relation to environmental context and resources, the major barrier to 
practitioners recommending HPV vaccination to patients was cost; for most practitioners this 
was their primary concern about vaccination. 
Linked to cost, practitioners perceived that there was an ethical difficulty associated with 
recommending to patients something that the practitioner knew patients could not afford 
(social/professional role and identity). Some practitioners mentioned that they were 
attempting to provide the HPV vaccine at a cheaper price (e.g., by buying in bulk, or forming 
a buying consortium with other practices) (behavioural regulation). Some practitioners had 
experienced a consultation about HPV vaccination where both mother and daughter were 
present and this was described as particularly ‘tricky’ to manage (skill) and as a ‘minefield’ 
(emotion). In addition, some noted that it could be difficult to determine whether a patient 
had been sexually active (skill). In terms of beliefs about capabilities, concerns were 
expressed about the ‘newness’ of the vaccines. Finally, some practitioners did not see patients 
in the relevant age group (nature of the behaviour) while others did not feel that HPV 
vaccination was necessary (motivation and goals). 
Factors that may influence clinical behaviours: HPV testing 
Nine of the 12 theoretical domains emerged in relation to HPV testing. The dominant ones 
were knowledge and beliefs about capabilities (Table 4). Fewer subthemes surfaced for HPV 
testing than for the other clinical areas. 
Table 4 Factors influencing behaviours related to HPV testing 
Theme / construct 
domain 
Subtheme / specific belief Practitioner 
* 
Sample 
quote 
Theme / construct domain 
GPs Practice Theme / construct domain 
Nurse 
1. Knowledge Not enough information 
available about it 
√ √ ‘I didn’t even know that it [HPV testing] was available… Whatever 
it is whether it’s a urine or a swab… Just don’t have the knowledge 
at all’  Don't know anything about it √ √ 
    - Practice nurse 5003 
2. Skill - - - - 
3. Social / 
professional role 
and identity 
Topic not covered in 
practitioner's training 
- √ ‘That wasn’t brought up inmy training or any of our updates’ 
- Practice nurse 5018 
4. Beliefs about 
capabilities 
The test is too new to 
implement in routine practice 
√ √ ‘We don’t have any algorithm for the management of people with 
HPV’ 
 Would be more likely to 
discuss HPV testing if: 
  
 There were guidelines / 
management algorithm 
√ √ 
 There was a reliable source to 
whom practitioners can refer 
questions 
√ - - GP 0140 
5. Beliefs about 
consequences 
HPV testing provides no 
clinical benefit 
√ √ ‘I’m not sure there’s any point, I can’t see the point in it really. It 
doesn’t seem to add an awful lot to [the treatment plan for women 
with cervical cancer], like given that you’re going to come up with 
a positive or negative test result to just HPV in geneeral mmm it 
doesn’t seem to add anything’ 
- GP 0133 
6. Motivation and 
goals 
HPV testing would be useful 
in primary care 
√ - ‘I think it would be good to provide HPV testing’ 
- GP 0129 
7. Memory, 
attention and 
decision processes 
- - - - 
8. Environmental 
context and 
resources 
HPV testing costs too much √ √ ‘From what I understand it’s very expensive’ 
- Practice nurse 5018 
9. Social influences More publicity is needed to 
encourage women to have a 
HPV test 
√ - ‘For the public to come forward [for HPV testing] a media 
campaign is always very good because if they read something in the 
daily papers they’ll take heed of it. They won’t take heed of us 
advising them a lot’ 
- GP 0086 
10. Emotion The practitioner could be 
embarrassed by not having 
answers to patients questions 
about HPV testing 
√ - ‘It’d be very difficult because it’d be mortifying not to have the 
answers straight away’ 
- GP 0034 
11. Behavioural 
regulation 
HPV testing is uncommon in 
Ireland 
- - - 
12. Nature of the 
behaviour 
HPV testing is uncommon in 
Ireland 
- √ ‘I don’t think it’s done an awful lot in Ireland’ 
- Practice nurse 5020 
* √ = Mentioned by at least one practitioner 
- = Not mentioned by any practitioners 
In terms of knowledge, there was very limited awareness of HPV testing and both GPs and 
practice nurses were unclear about what testing involved, how it was done and whether it was 
available in Ireland. Practitioners observed that there was a need for HPV testing guidelines 
or management algorithms, and these would make them more likely to consider offering 
testing (beliefs about capabilities). 
Some practitioners who were aware of HPV testing felt that there was uncertainty around its 
clinical benefit (beliefs about consequences). Emotion emerged in relation to professional 
embarrassment associated with not being able to answer patients’ questions about HPV 
testing. 
Discussion 
Roles and responsibilities 
A striking finding of the study was that male GPs had moved away from responsibility for 
smear taking; this was seen to be a predominantly female role. Furthermore, in recruiting to 
the study, it was particularly difficult to get male GPs to participate because they saw cervical 
cancer prevention as outside their remit. This means that practice nurses and female GPs may 
have more opportunity to raise HPV infection, vaccination, and testing with patients (e.g., 
while they are conducting smears). However, patients may ask a male GP questions about 
HPV, outside of the screening setting. Thus, it is important that male GPs keep up-to-date 
with developments around HPV and, specifically in relation to ATHENS, both male and 
female GPs should be targeted by any intervention in the area of HPV-related clinical 
practice. 
Factors that may influence clinical behaviours 
All theoretical domains emerged as influences on clinical practice. Only one—memory 
attention and decision processes—did not play a significant role but was mentioned by one 
participant in relation to one clinical behaviour. Even for HPV testing, which was very 
uncommon, nine of the domains emerged as potential influences on practice. This perhaps 
reflects how complex practitioners consider the topic of HPV to be. Some domains surfaced 
more strongly and these are discussed below. 
Emotion 
Various studies show that women consider HPV a sensitive topic because it is associated with 
sexual behaviour [34,35]. This was echoed in our study: practitioners observed that HPV 
infection is a sensitive topic for patients and gave this as a reason for not raising it in 
consultations. While it is likely that this theme would also emerge elsewhere, it is possible 
that it may be particularly strong in Ireland because of cultural and social norms around 
discussing or admitting sexual behaviour. For example, 2008 research among women in 
Ireland found that there was a considerable stigma attached to having smears because it was 
seen to be an admission of sexual activity [17,18]. Interestingly, the issue of sensitivity 
around HPV did not seem to be limited to patients; practitioners’ comments about HPV 
infection also revealed emotional influences. For example, they frequently talked about the 
difficulty of raising the subject with patients and the underlying tone of some interviews was 
tentative and awkward. One might expect that healthcare professionals would have ample 
experience of dealing with sensitive topics. Therefore, it is unclear whether there is 
something particularly challenging about HPV itself or whether practitioners’ emotions are 
influenced by their lack of knowledge, concerns about their ability to deal with patients’ 
reactions (skills), or other issues. Further research would be valuable to investigate the 
relationship between relevant theoretical constructs. 
Social influences 
Practitioners often stated that they did not discuss HPV with patients because they believed 
that patients either did not know anything, or did not want to know anything, about it. Studies 
in various counties have shown that there is limited knowledge about HPV amongst women 
[36-40]. However, a lack of knowledge is not universal, and a population survey of women in 
Ireland conducted in 2010 (O’Connor et al. 2010; personal communication) found that 44 % 
had heard of HPV infection and 55 % had heard of HPV vaccination. In addition, qualitative 
research among women in Ireland in 2008 found that, on learning about the link between 
HPV and cervical cancer, women were shocked, angry, and felt that this was a ‘secret’ that 
the medical community had kept from them [18,19]. Women also wanted to know more 
about HPV. Thus, it may be counterproductive for practitioners to assume that women have 
not heard of HPV or are not motivated to discuss it. Our findings also suggest that 
influencing practitioners’ perceptions about patient influences (e.g., a lack of desire to know 
about HPV) might increase the behaviour. We also found that practitioners’ reported that 
HPV infection is difficult to explain in a way that patients understand (skill), and there is 
insufficient time in consultations (environmental context and resources) suggesting that other 
factors interact with perceived social influences in relation to discussing HPV infection. It is 
also possible that reasons cited by practitioners for not discussing HPV infection may mask a 
reluctance of practitioners themselves to discuss the topic. 
Beliefs about consequences 
Beliefs about consequences was important in relation to both HPV infection and vaccination. 
For HPV infection, only negative consequences were raised, while for HPV vaccination, both 
positive and negative consequences emerged, with practitioners tending to discuss one aspect 
or the other. Of note, practitioners who raised concerns regarding vaccination safety were 
generally unaware that the death of a schoolgirl in the UK following vaccination was 
subsequently found to be unrelated to the vaccination [41]. The polarized views about the 
consequences of vaccination may reflect the fact that the HPV evidence-base is still evolving, 
particularly in relation to long-term efficacy and safety [12]. However, the fact that this 
domain was important suggests that influencing practitioners’ beliefs about consequences 
might influence their behaviours in relation to HPV. 
Knowledge 
Previous research found gaps in doctors’ HPV infection and vaccination knowledge [22,23]. 
This study confirms these and shows that primary care nurses also have limitations in their 
knowledge. Knowledge gaps were reported directly by practitioners, in their own words, and 
also became apparent through their responses to the clinical scenarios, meaning that 
practitioners varied in the extent to which they perceived that their knowledge was limited. 
Practitioners also described difficulties in keeping abreast of the clinical evidence; this has 
been identified as a barrier to primary care practice and patient care in other clinical areas 
[42-44]. 
Knowledge limitations, and the uncertainty expressed about current evidence, are perhaps not 
surprising given that the HPV vaccination programme in Ireland started only recently, data 
continues to emerge from the HPV vaccination trials [12], HPV testing is both relatively new 
and rare in primary care, and no clinical guidelines are in place. However, high-risk HPV 
infection was established as a necessary cause of cervical cancer a decade ago [2], and the 
key features of HPV infection have been clear for several years. For example, the same 
answers would be correct nowadays for all of the questions contained in the instrument 
developed by Jain et al. in 2004 to assess practitioners’ HPV infection knowledge [22]. 
Hence, there are probably fewer uncertainties in the evidence-base around HPV infection, 
and it is not as rapidly evolving, as practitioners perceive. 
It was noteworthy that CervicalCheck was seen as a trusted source for information on issues 
beyond smear taking (i.e., around HPV) given that CervicalCheck had not produced formal 
advice or practice guidelines in relation to HPV in primary care. While this finding suggests 
that practitioners hold CervicalCheck in high esteem, it probably also reflects the fact that 
HPV information is perceived not to be available elsewhere, or at least not from a source that 
practitioners view as trustworthy. 
For many practitioners, uncertainty around evidence flowed into an uncertainty about what to 
do in practice. Our analysis further suggested that this might have influenced how 
practitioners felt about the clinical areas and this, in turn, impacted on their practice (e.g., 
leading to avoidance). We also found a contrast between knowledge and beliefs about 
capabilities. Some GPs especially were high in self-efficacy although it was clear from the 
interviews that they lacked knowledge. This suggests knowledge to be a necessary 
intervention target, but shows that it is unlikely to influence clinical practice if other relevant 
key variables are not taken into account. Further research thus needs to establish how 
knowledge and other potentially relevant factors suggested in this study act together to 
influence behaviour. 
Reflections on using the TDF 
This study was the first stage in the development of an intervention, a process being guided 
by the MRC Framework for the Development of Complex Interventions [45,46]. Some 
investigators have observed that developing an intervention is time-consuming [47] and all 
studies, including ATHENS, have resource limitations. We applied the TDF, within a 
framework analysis approach [32], to analyse qualitative data collected using a topic guide 
not specifically based on the TDF domains. One of the main advantages of this was that the 
analysis was focused and efficient. The structured approach afforded by using the TDF to 
pre-define themes facilitated cross-checking the allocation of subthemes to themes and 
reaching analytical consensus. No influences on practitioners’ behaviours arose in the 
interviews that could not be classified according to the TDF, underlining the 
comprehensiveness of the framework. The possibility cannot be excluded that if a less 
structured analytical approach had been taken other aspects of clinical practice and 
experience might have emerged, but this risk is minimised by the wide range of 
psychological constructs included in the TDF. Equally, it is possible that a different analytical 
approach would have resulted in the themes being labelled or interpreted somewhat 
differently; this, however, could apply to almost all qualitative studies. A further strength of 
using the TDF was that our analysis was not prematurely confined to a particular 
psychological theory. This was, of course, a major rationale for the development of the TDF 
[30]. In our context, we had little a priori information on which to base the selection of 
appropriate theories. In view of the number of theoretical construct domains that emerged in 
relation to each clinical area, it was clear that using the TDF had strengthened the study: had 
we focussed from the outset on one or two theories (e.g., Theory of Planned Behaviour) [29], 
it is likely that we would have missed important influences on clinical behaviour and this 
would have impacted on the likely effectiveness of any intervention subsequently developed. 
The evidence base for HPV testing in cervical screening and efficacy of HPV vaccination 
continues to develop and to date there are no guidelines on HPV in primary care in Ireland. 
One potential limitation of the TDF is that it was designed for use in situations in which clear 
evidence-based clinical practice guidelines are in place. It has previously been suggested that 
the theoretical domains might be of less utility in situations without clear-cut guidelines or in 
which the evidence base is somewhat uncertain, because the effect of potential predictors 
might be overwhelmed by variations in attitudes [48]. This did not seem to be an issue in our 
context. Although there were variations in practice and attitudes, between nine and 12 of the 
domains were relevant to each clinical behaviour. 
A further potential limitation is that the TDF does not specify relationships between the 
construct domains. Our synthesis and interpretation suggested that there may be links 
between psychological constructs in influencing behaviour (e.g., between beliefs about 
capabilities and knowledge), but the TDF does not enable formal investigation of these links. 
Nor were we able to determine, other than in a qualitative way, which of the domains were 
likely to be the most important drivers of clinical behaviour. However, these limitations were 
in part a function of the qualitative study design, rather than the TDF per se. This study was 
the first step in an intervention development process and was intended to be hypothesis 
generating rather than hypothesis testing. Hence, we chose qualitative methods to provide a 
detailed picture of roles and responsibilities in clinical practice around cervical cancer 
prevention and to identify which domains may play a role. The next stage in the development 
process is a quantitative study in which we will determine the frequency of the behaviours of 
interest, identify the most important predictors of behaviours and investigate inter-
relationships between domains and constructs predicting these behaviours. We have used the 
results reported here to design a questionnaire for this quantitative study. This proved to be a 
very efficient method of questionnaire development. Questions were included covering the 
domains and subthemes that were reported by more than one practitioner; this helped in 
focusing and limiting the length of the questionnaire, and should reduce the possibility of 
redundant questions. The language used by interview participants was used to form question 
stems, which should enhance face validity. The questionnaire study is currently under way. 
Conclusions 
The findings of this study confirm the need for an intervention to support primary care 
practitioners in their HPV-related practice. This intervention should target both male and 
female practitioners and should be directed towards discussing HPV infection with female 
patients, offering or recommending HPV vaccination to appropriate patients and answering 
patients’ questions around HPV testing. Such an intervention is more likely to be effective if 
it is aimed at a range of theoretical domains. The TDF proved valuable in analysing 
qualitative data collected using a topic guide not specifically designed to capture TDF 
domains, and understanding clinical behaviours in an area with an evolving evidence-base. 
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